Prevelance of Hypercalciuria in Children With Steroid Dependent Nephrotic Syndrome

NCT ID: NCT07194213

Last Updated: 2025-09-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-01

Study Completion Date

2026-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prevelance of hypercalciurea in children with sterorid dependent nephrotic syndrome

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prevelance of hypercalciurea in steroid dependent nephrotic syndrome

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Steroid-Dependent Nephrotic Syndrome; Hypercalciuria Steroid Dependent Nephrotic Syndrome Hupercalciurea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Children with steroid dependent nephrotic syndrome

Participants will undergo urine analysis to measure calcium excretion in order to assess the prevalence of hypercalciuria. No experimental treatment will be given.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \- Age between 2 and 16 years.
* Diagnosis of steroid-dependent nephrotic syndrome (according to standard clinical criteria).
* Currently in remission or relapse while on steroid therapy.

Exclusion Criteria

* \- Children with congenital or secondary nephrotic syndrome.
* Presence of other chronic kidney diseases.
* Use of medications that affect calcium metabolism (other than steroids).
* Children with systemic diseases affecting bone or mineral metabolism.
Minimum Eligible Age

2 Years

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed Ewees Elsayed

Ahmed ewees

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sohag university hospital

Sohag, , Egypt

Site Status

Sohag university hospital

Sohag, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh-Med--25-7-8MS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.